These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24337703)

  • 41. Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells.
    Shibata T; Tamura M; Kabashima N; Serino R; Tokunaga M; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Life Sci; 2009 May; 84(21-22):725-31. PubMed ID: 19254730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
    Garwood ER; Kumar AS; Baehner FL; Moore DH; Au A; Hylton N; Flowers CI; Garber J; Lesnikoski BA; Hwang ES; Olopade O; Port ER; Campbell M; Esserman LJ
    Breast Cancer Res Treat; 2010 Jan; 119(1):137-44. PubMed ID: 19728082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma.
    Clendening JW; Pandyra A; Li Z; Boutros PC; Martirosyan A; Lehner R; Jurisica I; Trudel S; Penn LZ
    Blood; 2010 Jun; 115(23):4787-97. PubMed ID: 20360469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells.
    Ito T; Ikeda U; Yamamoto K; Shimada K
    Atherosclerosis; 2002 Nov; 165(1):51-5. PubMed ID: 12208470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line.
    Sławińska-Brych A; Zdzisińska B; Kandefer-Szerszeń M
    Pharmacol Rep; 2014 Feb; 66(1):121-9. PubMed ID: 24905317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mevalonate is essential for growth of porcine and human vascular smooth muscle cells in vitro.
    Rogler G; Lackner KJ; Schmitz G
    Basic Res Cardiol; 1995; 90(6):443-50. PubMed ID: 8773189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
    Budman DR; Tai J; Calabro A
    Breast Cancer Res Treat; 2007 Jul; 104(1):93-101. PubMed ID: 17004104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
    Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism.
    Abe K; Nakayama M; Yoshimura M; Nakamura S; Ito T; Yamamuro M; Sakamoto T; Miyamoto Y; Yoshimasa Y; Saito Y; Nakao K; Yasue H; Ogawa H
    Pharmacogenet Genomics; 2005 May; 15(5):329-36. PubMed ID: 15864134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage.
    Xu Y; Du HP; Li J; Xu R; Wang YL; You SJ; Liu H; Wang F; Cao YJ; Liu CF; Hu LF
    Pharmacol Res; 2014 Sep; 87():18-25. PubMed ID: 24951966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluvastatin and fluvastatin extended release: a clinical and safety profile.
    Asberg A; Holdaas H
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):641-52. PubMed ID: 15350166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
    Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
    Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluvastatin mediated breast cancer cell death: a proteomic approach to identify differentially regulated proteins in MDA-MB-231 cells.
    Kanugula AK; Dhople VM; Völker U; Ummanni R; Kotamraju S
    PLoS One; 2014; 9(9):e108890. PubMed ID: 25268751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.
    Nash JD; Burgess DS; Talbert RL
    J Med Microbiol; 2002 Feb; 51(2):105-109. PubMed ID: 11863260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluvastatin increases tyrosinase synthesis induced by alpha-melanocyte-stimulating hormone in B16F10 melanoma cells.
    Galus R; Niderla J; Sladowski D; Sajjad E; Włodarski K; Jóźwiak J
    Pharmacol Rep; 2010; 62(1):164-9. PubMed ID: 20360626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells.
    Göbel A; Breining D; Rauner M; Hofbauer LC; Rachner TD
    Cell Death Dis; 2019 Jan; 10(2):91. PubMed ID: 30692522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.
    Suzumura K; Tanaka K; Yasuhara M; Narita H
    Biol Pharm Bull; 2000 Jul; 23(7):873-8. PubMed ID: 10919369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.